24 results on '"Niu, Yuan-Jie"'
Search Results
2. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
- Author
-
Xu, Jian, Li, Gang, Zhu, Shi Miao, Cai, Qi Liang, Wang, Zhun, Yang, Xiong, Zhang, Hong Tan, and Niu, Yuan Jie
- Published
- 2019
- Full Text
- View/download PDF
3. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling
- Author
-
Ding, Xianfan, Yang, Dong-Rong, Lee, Soo Ok, Chen, Ya-Ling, Xia, Liqun, Lin, Shin-Jen, Yu, Shicheng, Niu, Yuan-Jie, Li, Gonghui, and Chang, Chawnshang
- Published
- 2015
- Full Text
- View/download PDF
4. Androgen receptor roles in benign and malignant prostate disease
- Author
-
Wang, Juan, Shang, Zhi-qun, and Niu, Yuan-jie
- Published
- 2011
- Full Text
- View/download PDF
5. Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells
- Author
-
Altuwaijri, Saleh, Wu, Cheng-Chia, Niu, Yuan-Jie, Mizokami, Atsushi, Chang, Hong-Chiang, and Chang, Chawnshang
- Published
- 2007
6. Comparison of Two Numerical Parameters to Assess Detrusor Contractility in Prognosing Short-Term Outcome after Transurethral Resection of the Prostate.
- Author
-
Zhong, Ping, Zhao, Yao-Rui, Qiao, Bao-Min, Yang, Fu-Jiang, Zhu, Yan, Yang, Zhi-Qiang, and Niu, Yuan-Jie
- Subjects
TRANSURETHRAL prostatectomy ,RECEIVER operating characteristic curves ,LOGISTIC regression analysis - Abstract
Objective: To investigate and compare the influence of two numerical detrusor contractility parameters, the bladder contractility index (BCI) and the maximum Watts factor (WF
max ), on transurethral resection of the prostate (TURP) outcome. Methods: A retrospective study was conducted on 236 patients who had undergone urodynamic assessment preoperatively and TURP for benign prostatic obstruction. They were evaluated by International Prostate Symptom Score (IPSS) and uroflowmetry preoperatively and 3 months postoperatively. Related criteria were established to determine the overall efficacy of TURP. Logistic regression analysis and receiver operating characteristic curves were made to investigate the influence of the BCI and WFmax on TURP efficacy. Results: Among the 236 patients, 195 treatments were effective and 41 ineffective. Multivariate analysis showed that both the BCI (OR 1.038) and the WFmax (OR 1.291) could influence TURP efficacy. For predicting TURP efficacy, the optimal cut-off values of the BCI and WFmax were 98.7 and 10.27 W/m2 , respectively. The AUC, sensitivity and specificity of the BCI were 0.722, 78.5% and 61.0%; those of the WFmax were 0.761, 73.9% and 73.2%, with no significant difference (p > 0.05). Conclusions: To some extent, the BCI and the WFmax can predict TURP efficacy equally well. A discrimination level of 10.27 W/m2 may be a threshold value for detrusor underactivity (DU); as regards the BCI, the current threshold value is appropriate to diagnose DU. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
7. Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population.
- Author
-
Zhu, Yan, Zhao, Yao‐Rui, Yang, Xian‐Fa, Wei, Mao‐Ti, Niu, Yuan‐Jie, Chang, Ji‐Wu, Wang, Ai‐Xiang, and Liang, Xuan
- Subjects
RENAL cell carcinoma ,PLATELET count ,NEPHRECTOMY ,LOG-rank test ,MULTIVARIATE analysis - Abstract
Objectives: To develop a predictive model for the oncological outcomes of clear cell renal cell carcinoma in a Chinese population. Methods: A retrospective study of 1108 patients with clear cell renal cell carcinoma who underwent nephrectomy or partial nephrectomy between January 2006 and December 2013 was carried out. Recurrence‐free survival was calculated using Kaplan–Meier analysis. Differences between the groups were compared using the log–rank test. Cox proportional hazard regression was used to test associations between features and outcomes. The discriminative ability of the models was validated using Harrell's concordance index and bootstrapping. Results: Overall, 942 patients who met the inclusion criteria had been followed. The median follow‐up period was 72 months (range 1–143 months). Multivariate analysis showed that age, Eastern Cooperative Oncology Group performance status, preoperative platelet count, neutrophil‐to‐lymphocyte ratio, tumor size, 2010 tumor stage (pT3 and pT4) and Fuhrman nuclear grade were independent risk factors affecting recurrence‐free survival in clear cell renal cell carcinoma patients (P < 0.05). These factors were assigned to develop a new model. The patients were divided into three groups based on the risk of recurrence. The difference among the prognoses of patients in the three groups was statistically significant (P < 0.05). The concordance index for our new model and that for Leibovich's 2018 model were 0.791 and 0.750, respectively. Conclusions: In the present study, the new model has a higher concordance index than does Leibovich's 2018 model of clear cell renal cell carcinoma in the Asian population, with no added pain for patients. This new model might be an appropriate risk stratification tool for clinical work. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
- Author
-
Niu, Jun-Tao, Zhang, Li-Jun, Huang, Yong-Wang, Li, Chao, Jiang, Ning, and Niu, Yuan-Jie
- Subjects
SQUAMOUS cell carcinoma ,TRANSCRIPTION factors ,IMMUNOHISTOCHEMISTRY ,MICRORNA ,CANCER cells - Abstract
Copyright of Biochemistry & Cell Biology is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
- Full Text
- View/download PDF
9. Paraganglioma of the prostate: A case report and review of the literature.
- Author
-
Chen Jing, Quan Chang-yi, Jiang Ning, and Niu Yuan-jie
- Published
- 2012
10. Prostate cancer with five different histological features: A case report and review of the literature.
- Author
-
CHENG Jing, QUAN Chang-yi, CHANG Ji-wu, YANG Yu-ming, LI Bo, CHANG Wen-liang, WANG Jiang, and NIU Yuan-jie
- Published
- 2011
11. Clinicopathological characteristics and typing of multilocular cystic renal neoplasm of low malignant potential.
- Author
-
Gao WL, Li G, Zhu DS, and Niu YJ
- Abstract
Background: Up until now, no research has been reported on the association between the clinical growth rate of multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) and computed tomography (CT) imaging characteristics. Our study sought to examine the correlation between them, with the objective of distinguishing unique features of MCRNLMP from renal cysts and exploring effective management strategies., Aim: To investigate optimal management strategies of MCRNLMP., Methods: We retrospectively collected and analyzed data from 1520 patients, comprising 1444 with renal cysts and 76 with MCRNLMP, who underwent renal cyst decompression, radical nephrectomy, or nephron-sparing surgery for renal cystic disease between January 2013 and December 2021 at our institution. Detection of MCRNLMP utilized the Bosniak classification for imaging and the 2016 World Health Organization criteria for clinical pathology., Results: Our meticulous exploration has revealed compelling findings on the occurrence of MCRNLMP. Precisely, it comprises 1.48% of all cases involving simple renal cysts, 5.26% of those with complex renal cysts, and a noteworthy 12.11% of renal tumors coexisting with renal cysts, indicating a statistically significant difference ( P = 0.001). Moreover, MCRNLMP constituted a significant 22.37% of the patient population whose cysts demonstrated a rapid growth rate of ≥ 2.0 cm/year, whereas it only represented 0.66% among those with a growth rate below 2.0 cm/year. Of the 76 MCRNLMP cases studied, none of the nine patients who underwent subsequent nephron-sparing surgery or radical nephrectomy following renal cyst decompression experienced recurrence or metastasis. In the remaining 67 patients, who were actively monitored over a 3-year postoperative period, only one showed suspicious recurrence on CT scans., Conclusion: MCRNLMP can be tentatively identified and categorized into three types based on CT scanning and growth rate indicators. In treating MCRNLMP, partial nephrectomy is preferred, while radical nephrectomy should be minimized. After surgery, active monitoring is advisable to prevent unnecessary nephrectomy., Competing Interests: Conflict-of-interest statement: All authors have no conflicts of interest to disclose., (©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
12. [Normative diagnosis and treatment of small penis].
- Author
-
Liu GZ, Niu YJ, and Bai WJ
- Subjects
- Humans, Hypogonadism complications, Infertility, Male complications, Male, Quality of Life, Genital Diseases, Male diagnosis, Genital Diseases, Male therapy, Penis abnormalities
- Abstract
Small penis is a disease of sexual dysplasia, which might be related to chromosome or genetic abnormalities, pubertal dysplasia, endocrine abnormality, and other factors. Hypogonadism is common in small penis. Children with small penis often have small testes, short stature, and male secondary sexual deficiencies, and the incidence of infertility is high in adulthood. Small penis can be early detected by accurately measuring the stretched penile length, screening the pathogenic causes, and differentiating it from buried or concealed penis. Once definite diagnosis is made, positive clinical intervention should be initiated. Early treatment can improve the prognosis of small penis, the patient's quality of life and the rate of natural pregnancy.
- Published
- 2019
13. Classification of positive surgical margins and tumor recurrence after nephron-sparing surgery for small renal masses.
- Author
-
Li G, Zhu DS, Lang ZQ, Wang AX, Li YH, Zhang RY, and Niu YJ
- Abstract
Background: The association of positive margin and local recurrence after nephron-sparing surgery (NSS) remains a notably controversial issue. The aim of the present study was to investigate the relationship between classification of positive surgical margins (PSMs) and tumor recurrence based pathological findings., Methods: Clinical, pathological, and follow-up data of 600 small renal cancer patients who underwent NSS between November 2007 and November 2017 at four hospitals in China were analyzed retrospectively., Results: Of the 600 reviewed patients, 20 had positive margins. During the follow-up period of 56 months, only three cases of tumor recurrence were identified. Pathological examination was performed, and subsequently a new classification criteria were proposed: 1) False PSMs, which could be further divided into three subtypes: i) no standard processing performed on pathological specimens (seven patients); ii) incidental incision into the tumor during operation, with the tumor bed free of tumor residues (four patients); iii) part of the tumor pseudocapsule was noted to be remained in the tumor bed, with no signs of tumor residue (four patients). 2) True PSMs with two subtypes: i) a large number of residual tumor cells at the surgical margin (three patients); ii) incision of satellite tumor nodules detected around a large tumor (two patients)., Conclusion: Taken together, PSMs in NSS were rarely found. Based on the pathological examination findings, PSMs can be divided into false positive and true positive. This being said, PSMs were determined to be poor predictors for local recurrence, with no predominant association with true tumor remnants in the majority of our evaluated cases. Through the key findings of our study, we concluded that PSMs should be carefully analyzed and treated on a case-by-case basis., Competing Interests: Disclosure The authors report no conflicts of interest in this work.
- Published
- 2018
- Full Text
- View/download PDF
14. [Correlation between the expression of Pim-1 and androgen-deprivation therapy for prostate cancer].
- Author
-
Wang J, Quan CY, Chang WL, Shang ZQ, Jiang N, Li B, and Niu YJ
- Subjects
- Animals, Disease Progression, Gene Expression, Heterografts, Humans, Male, Mice, Mice, Inbred BALB C, Mice, Nude, Neoplasms, Hormone-Dependent metabolism, Prostate-Specific Antigen metabolism, Prostatic Neoplasms, Castration-Resistant genetics, Prostatic Neoplasms, Castration-Resistant metabolism, Receptors, Androgen metabolism, Androgen Antagonists therapeutic use, Prostatic Neoplasms, Castration-Resistant therapy, Proto-Oncogene Proteins c-pim-1 metabolism
- Abstract
Objective: To investigate the expression of the Pim-1 gene in the LNCaP cells of the animal model of orthotopically implanted prostate cancer by surgical castration simulating androgen-deprivation therapy., Methods: We equally allocated 32 male BALBc-nu mice into 4 groups, androgen-dependent prostate cancer (ADPC), androgen-deprivation therapy (ADT) , castration-resistant prostate cancer (CRPC) and blank control, and established the models of orthotopically implanted tumor using human prostate cancer LNCaP cells. We detected and ,compared the expressions of Pim-1, PSA, and androgen receptor (AR) in the tumor tissues of different groups by RT-PCR. qRT-PCR, ELSIA and immunohistochemistry., Results: The relative gray scales in the ADPC and CRPC groups were 0.59 ± 0.01 and 1.14 ± 0.02, with statistically significant differences from 0.62 ± 0.03 in the ADT group (P < 0.05), and the Δ Ct values of Pim-1 were 6.15 ± 0.34 and 4.56 ± 0.23 in the former two groups, also with significant differences from 5.11 ± 0.21 in the latter (P < 0.05). The results of 2-ΔΔ Ct relative quantification analysis showed that the amplification products of Pim-1 in the ADT and CRPC groups increased 2.05 and 3.01 times respectively that of the ADPC group. The concentration of PSA was significantly higher in the ADPC ([480 ± 25] pg/ml) and CRPC ([870 ± 23] pg/ml) than in the ADT ([170 ± 32] pg/ml) and blank control groups (0 µg/L) (P < 0.01). The mean optical densities of Pim-1 and AR proteins were 0.017 ± 0.002 and 0.032 ± 0.009 in the ADPC group and 0.024 ± 0.002 and 0.040 ± 0.011 in the CRPC group, both with significant differences from those in the ADT group (0.018 ± 0.001 and 0.019 ± 0.006) (P < 0.01)., Conclusion: Pim-1 is highly expressed in nude mice with prostate cancer receiving androgen-deprivation therapy and plays an important role in the progression and metastasis of prostate cancer.
- Published
- 2015
15. [Epithelial mesenchymal transition in prostate cancer: Advances in current research].
- Author
-
Yan B, Jiang N, and Niu YJ
- Subjects
- Biomedical Research, Cell Differentiation, Disease Progression, Humans, Male, Neoplastic Stem Cells physiology, Epithelial Cells physiology, Epithelial-Mesenchymal Transition physiology, Mesenchymal Stem Cells, Prostatic Neoplasms pathology
- Abstract
Epithelial mesenchymal transition (EMT) is a process of normal cell physiological development, in which epithelial cells transform into mesenchyme cells through a specific program. EMT plays a key role in inflammatory reaction, cell development, tumor invasion, and metastasis and has an interrelation with prostate cancer stem cells. Recent researches show the involvement of EMT in the development and metastasis of prostate cancer. This article reviews the specific roles and action mechanisms of EMT in the progression of prostate cancer.
- Published
- 2015
16. What is the next generation therapeutic strategy for castration-resistant prostate cancer.
- Author
-
Wen SM, Quan CY, Jiang N, Shang ZQ, and Niu YJ
- Subjects
- Animals, Humans, Male, Azepines pharmacology, Nuclear Proteins chemistry, Prostatic Neoplasms, Castration-Resistant drug therapy, Transcription Factors chemistry, Triazoles pharmacology
- Abstract
Prostate cancer (PCa) is one of the most common cancers in the world. Since androgen receptor (AR) signal plays key roles in the PCa progression, targeting androgens via the current androgen deprivation therapy (ADT) is the main therapeutic strategy for advanced PCa. However, most patients who receive ADT, including the second generation anti-androgens enzalutamide (also known as MDV3100) may finally develop the castration (or anti-androgen) resistance after 12-24 months treatment. In the manuscript by Asangani et al., the authors demonstrated that targeting the amino-terminal bromodomains of BRD4 could preferentially suppress human castration-resistant prostate cancer (CRPC) cell lines. While further studies are required to understand the full impact of their findings, the innovative approach provides a potential novel epigenetic approach for the concerted blockade of oncogenic drivers in CRPC.
- Published
- 2015
- Full Text
- View/download PDF
17. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study.
- Author
-
Qiao LD, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM, Zhao XK, Gao XF, Chen M, and Tian Y
- Abstract
Objective: This study assessed the characteristics of pathogens identified in clinical isolates from patients with urinary tract infection (UTI) and their in vitro sensitivity to commonly used antibiotics in the clinical setting in China., Design and Setting: Multicenter study was conducted between January and December 2011 in 12 hospitals in China., Participants: Urine samples were collected from 356 symptomatic patients treated in the study hospitals for acute uncomplicated cystitis, recurrent UTI or complicated UTI., Primary and Secondary Outcome Measures: Minimal inhibitory concentrations (MICs) were measured using broth microdilution according to the Clinical and Laboratory Standards Institute 2011 guidelines. Thirteen antimicrobial agents were tested: fosfomycin tromethamine, levofloxacin, moxifloxacin, cefdinir, cefixime, cefaclor, cefprozil, cefuroxime, amoxicillin/clavulanic acid, cefotaxime, azithromycin, nitrofurantoin and oxacillin. Escherichia coli isolates were screened and extended spectrum β-lactamases (ESBL) production was confirmed by a double-disk synergy test., Results: 198 urine samples were culture-positive and 175 isolates were included in the final analysis. E coli was detected in 50% of cultures, followed by Staphylococcus epidermidis (9%), Enterococcus faecalis (9%) and Klebsiella pneumoniae (5%). The detection rate of ESBL-producing E coli was 53%. Resistance to levofloxacin was the most common among all the isolates. Nitrofurantoin and fosfomycin tromethamine had the greatest activity against E coli; overall, 92% and 91% of isolates were susceptible to these antimicrobials. E faecalis had the highest susceptibility rates to fosfomycin tromethamine (100%)., Conclusions: The most frequently identified pathogens in our patients were ESBL-producing E coli and E faecalis. Fosfomycin tromethamine and nitrofurantoin showed a good antimicrobial activity against UTI pathogens. They may represent good options for the empiric treatment of patients with UTI.
- Published
- 2013
- Full Text
- View/download PDF
18. Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study.
- Author
-
Qiao LD, Zheng B, Chen S, Yang Y, Zhang K, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM, Zhao XK, Gao XF, and Chen M
- Abstract
Objective: To evaluate the clinical and microbiological efficacy and safety of three doses of 3 g fosfomycin tromethamine administered orally to treat lower urinary tract infections., Design and Participants: This prospective, uncontrolled, open-label study was conducted in 12 medical centres in China, between January and December 2011. According to the diagnosis criteria of Chinese Guidelines on Urological Infections, patients (18-70 years) with acute uncomplicated cystitis, recurrent lower urinary tract infection or complicated lower urinary tract infection received three doses of 3 g fosfomycin tromethamine orally, at days 1, 3 and 5., Primary and Secondary Outcome Measures: Efficacy endpoints (clinical efficacy, microbiological efficacy and overall efficacy) were evaluated on day 15. Clinical symptoms, physical signs, urinalysis, liver and kidney function, patient records and evaluation of adverse events (AEs) and serious AEs up to day 15 were evaluated for analysis of safety., Results: 361 patients were included in the full analysis set, 356 in the safety analysis set and 335 in the per-protocol set (PPS). In the PPS, the clinical efficacy rates at day 15 for acute uncomplicated cystitis, recurrent lower urinary tract infection and complicated lower urinary tract infection were 94.71% (179/189), 77.22% (61/79) and 62.69% (42/67), respectively. The microbiological efficacy rates (day 15) were 97.65% (83/85), 94.44% (34/36) and 83.87% (26/31), respectively. The overall efficacy rates (day 15) were 95.29% (81/85), 77.78% (28/36) and 64.52% (20/31), respectively. 20/356 (5.6%) patients reported drug-related AEs, the most common being diarrhoea. No serious drug-related AEs were reported., Conclusions: This fosfomycin tromethamine dosing regimen showed clinical and microbiological efficacy with some AEs and good tolerability in patients with acute uncomplicated cystitis, recurrent lower urinary tract infection and complicated lower urinary tract infection.
- Published
- 2013
- Full Text
- View/download PDF
19. [Giant prostatic calculus with neurogenic bladder disease and prostate diverticulum: a case report and review of the literature].
- Author
-
Li XS, Quan CY, Li G, Cai QL, Hu B, Wang JW, and Niu YJ
- Subjects
- Adult, Humans, Male, Calculi complications, Diverticulum complications, Prostatic Diseases complications, Urinary Bladder, Neurogenic complications
- Abstract
Objective: To study the etiology, clinical manifestation, diagnosis and treatment of giant prostatic calculus with neurogenic bladder disease and prostate diverticulum., Methods: We retrospectively analyzed the clinical data of a case of giant prostatic calculus with neurogenic bladder disease and prostate diverticulum and reviewed the relevant literature. The patient was a 37-year-old man, with urinary incontinence for 22 years and intermittent dysuria with frequent micturition for 9 years, aggravated in the past 3 months. He had received surgery for spina bifida and giant vesico-prostatic calculus. The results of preoperative routine urinary examination were as follows: WBC 17 -20/HPF, RBC 12 - 15/HPF. KUB, IVU and pelvic CT revealed spina bifida occulta, neurogenic bladder and giant prostatic calculus., Results: The patient underwent TURP and transurethral lithotripsy with holmium-YAG laser. The prostatic calculus was carbonate apatite in composition. Urinary dynamic images at 2 weeks after surgery exhibited significant improvement in the highest urine flow rate and residual urine volume. Seventeen months of postoperative follow-up showed dramatically improved urinary incontinence and thicker urine stream., Conclusion: Prostate diverticulum with prostatic giant calculus is very rare, and neurogenic bladder may play a role in its etiology. Cystoscopy is an accurate screening method for its diagnosis. For the young patients and those who wish to retain sexual function, TURP combined with holmium laser lithotripsy can be employed, and intraoperative rectal examination should be taken to ensure complete removal of calculi.
- Published
- 2013
20. Association of the polymorphism of APE1 gene with the risk of prostate cancer in Chinese Han population.
- Author
-
Jing B, Wang J, Chang WL, Li B, Chen J, and Niu YJ
- Subjects
- Aged, Base Sequence, Case-Control Studies, China, DNA Primers, Humans, Male, Polymerase Chain Reaction, Polymorphism, Restriction Fragment Length, DNA-(Apurinic or Apyrimidinic Site) Lyase genetics, Ethnicity, Genetic Predisposition to Disease, Polymorphism, Genetic, Prostatic Neoplasms genetics
- Abstract
Background: DNA damage, caused by numerous carcinogens, contributes to the increased risk of different types of cancer. The base excision repair (BER) pathway including the apurinic/apyrimidic endonuclease (APE1, also known as APEX1) gene plays an important role in preventing the accumulation of DNA damage and maintaining genomic stability. The aim of the present study is to determine whether polymorphisms of APE1 are associated with the risk of prostate cancer (PCa) in the Chinese Han population., Methods: This study consisted of 198 patients with PCa and 156 healthy controls. The polymorphisms of APE1, Asp148Glu (rs1130409) and -141T/G (rs1760944) were determined by the polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method., Results: The genotypic distributions of the two polymorphisms in controls were in Hardy-Weinberg equilibrium (p = 0.92 and p = 0.83, respectively). Logistic regression analysis indicated that the -141GG genotype was significantly associated with a decreased risk of PCa compared with the -141TT genotype (p = 0.03; OR 0.49; 95% CI 0.26 - 0.92). The G allele was also significantly associated with a reduced risk of PCa compared with the T allele (p = 0.02; OR 0.71; 95% CI 0.52 - 0.96). However, no association between Asp148Glu polymorphism and the risk of PCa was found., Conclusions: The -141GG genotype and G allele of the APE1 gene are associated with a decreased risk of PCa in the Chinese Han population.
- Published
- 2013
- Full Text
- View/download PDF
21. [Undifferentiated prostate sarcoma with cartilage metaplasia: a case report and review of the literature].
- Author
-
Chen J, Quan CY, Chang JW, Yang YM, Li B, Chang WL, Wang J, Jin B, and Niu YJ
- Subjects
- Adult, Humans, Male, Metaplasia, Prostatic Neoplasms diagnosis, Sarcoma diagnosis, Cartilage pathology, Prostate pathology, Prostatic Neoplasms pathology, Sarcoma pathology
- Abstract
Objective: To investigate the clinical presentations and pathologic features of undifferentiated sarcoma of the prostate with cartilage metaplasia, and to clarify its category., Methods: We analyzed the clinical data of a case of undifferentiated sarcoma of the prostate with cartilage metaplasia treated by surgical resection. The tumor tissue was subjected to routine HE and immunohistochemical staining, its histological structure and immunohistochemical expression were observed under the light microscope, and relevant literature on its manifestations was reviewed., Results: The case was pathologically diagnosed as gray prostate tumor, with chondrosarcomatous and undifferentiated malignant mesenchymal components under the light microscope. Immunohistochemical staining revealed vimentin (+), local CD117 (+/-), SMA (-), Des (-), myoglobin (-), CD34 (-), CK7 (-), and CK8 (-). Tumor metastasis was found 2 months after the operation, and the patient died 4 months later., Conclusion: Undifferentiated sarcoma of the prostate with cartilage metaplasia is a very rare and highly malignant aggressive tumor, which can be diagnosed by biopsy and immunohistochemistry.
- Published
- 2011
22. [Prostate cancer with five different histological features: a case report and review of the literature].
- Author
-
Chen J, Quan CY, Chang JW, Yang YM, Li B, Chang WL, Wang J, and Niu YJ
- Subjects
- Aged, 80 and over, Biopsy, Humans, Male, Adenocarcinoma, Mucinous pathology, Prostatic Neoplasms pathology
- Abstract
Objective: To study the clinical manifestations, pathological characteristics and treatment methods of prostate cancer with five different histological features., Methods: We reported 1 case of prostate cancer with five different histological features and further analyzed the diagnosis, pathology and treatment of the disease by reviewing the relevant literature., Results: The patient was an 84-year-old male, admitted due to difficult urination and dribbling urine for 1 year, hematuria for 8 months and deterioration for 2 weeks. Prostate cancer was indicated by rectal examination, ultrasonography, CT, MRI and PSA, and confirmed by biopsy. Considering the general condition of the patient, we performed electrotransurethral resection under epidural anesthesia to alleviate his urinary symptoms and remove suspected tumor tissues. Postoperative pathology showed the case to be prostate adenocarcinoma, histologically characterized by cribriform carcinoma, acinar carcinoma, diffuse invasive carcinoma, ductal carcinoma, and mucinous adenocarcinoma, with a Gleason score of 9. Bicalutamide and goserelin were administered postoperatively. Systemic metastasis occurred 10 months later, and the patient died 1 year after the operation., Conclusion: Prostate cancer with five different histological features is extremely rare. Its early diagnosis is difficult and mainly depends on pathological and immunohistochemical examinations, and radical prostatectomy can be considered for its treatment.
- Published
- 2011
23. [Effect of recombinant hIFN-alpha-2b-BCG on mouse bladder tumor MB49 cells in vitro].
- Author
-
Sun EL, Fan XD, Han RF, and Niu YJ
- Subjects
- Adjuvants, Immunologic pharmacology, Animals, Antineoplastic Agents pharmacology, Cell Line, Tumor, Cytotoxicity, Immunologic, Histocompatibility Antigens Class I metabolism, Interferon alpha-2, Mice, Recombinant Proteins pharmacology, Urinary Bladder Neoplasms metabolism, Apoptosis drug effects, BCG Vaccine pharmacology, Cell Proliferation drug effects, Interferon-alpha pharmacology, Urinary Bladder Neoplasms pathology
- Abstract
Objective: To investigate the antitumor effect of recombinant IFN-alpha-2b-BCG on mouse bladder cancer MB49 cells in vitro, and to explore its antitumor mechanisms., Methods: MB49 cells were co-cultured with recombinant BCG or wild BCG, and than were examined by light and transmission electron microscopy. The cell growth was assessed by MTT assay, and apoptosis rate and MHC-I of the MB49 cells was detected by flow cytometry using AO and Hoechst33258 fluorescence immunostaining., Results: The hIFN-alpha-2b-BCG-treated tumor cells showed slow growth, detachment of some cells, and various degree of degeneration. Light microscopy revealed organelle disorganization, chromatin aggregation, nuclear pyknosis, and cytolysis in some cells. Cellular membrane bulged and some bubbles were seen under fluorescence microscope using AO staining. Hoechst33258 assay also depicted frequent apoptosis in the tumor cells. The MTT assay showed that rBCG more actively than the wild BCG inhibited the proliferation of MB49 cells. The apoptosis rate of the recombinant BCG group was 19.7% and 46.6% at the time point of 24 h and 48 h, respectively, significantly higher than 10.8% and 20.9%, respectively, in the wild BCG group. The results of flow cytometry indicated that both types of BCG enhanced the expression of MHC-I in the MB49 cells, but more effective in the recombinant BCG group., Conclusion: The recombinant hIFN-alpha-2b-BCG has more strong immuno-modulatory properties, anti-tumor effect on MB49 cells and induces apparent cytotoxicity in the bladder cancer cells in vitro.
- Published
- 2010
24. Androgen and prostatic stroma.
- Author
-
Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, and Sun G
- Subjects
- Animals, Biomarkers, Cell Differentiation drug effects, Cell Differentiation physiology, Cell Division drug effects, Cell Division physiology, Cells, Cultured, Dihydrotestosterone pharmacology, Dogs, Estradiol blood, Fibroblast Growth Factor 2 genetics, Fibroblast Growth Factor 2 pharmacology, Gene Expression, Humans, Male, Muscle, Smooth cytology, Muscle, Smooth physiology, Orchiectomy, Prostate cytology, RNA, Messenger analysis, Receptors, Androgen genetics, Receptors, Estrogen genetics, Stromal Cells cytology, Transforming Growth Factor beta genetics, Transforming Growth Factor beta pharmacology, Prostate physiology, Prostatic Hyperplasia physiopathology, Stromal Cells physiology, Testosterone blood
- Abstract
Aim: To investigate the effect of androgen on the proliferation, differentiation and regression of canine prostatic stromal cells in vivo and human stromal cells in vitro., Methods: Twenty-two dogs, including 15 normal prostate dogs and 7 prostatic hyperplasia dogs, had their serum concentration of testosterone and estrodiol determined by radioimmunoassay before and after castration. The expression of androgen receptor (AR) and estrogen receptor (ER) in the prostate were analysed by immunohistochemistry and semi-quantitative RT-PCR before and after castration. Light microscopy, transmission electron microscopy and TUNEL assay were carried out successively before and after castration to evaluate the prostatic histomorphology. In vitro serum-free cell cultures from human prostatic stroma were established and exposed to dihydrotestosterone (DHT). The proliferation of the cell culture was detected by MTT assay. The expression of TGFbgr, bFGF, AR, and smooth muscle cell (SMC) specific proteins (myosin and/or smoothelin) were detected using immunohistochemistry and RT-PCR. The differentiation from fibroblasts to smooth muscle cells was deduced by measuring the expression of SMC specific proteins., Results: Before castration, the serum concentrations of testosterone and estrodiol were not statistically different between normal and hyperplasia groups. Following castration, the serum concentration of testosterone decreased rapidly in 2 days, and the concentration of estrodiol had no significant change compared with the pre-castration data. In the prostate, AR was presented in both the epithelial and stromal cells and the AR mRNA level was higher in hyperplasia than in normal prostate tissues (P<0.05). While ER predominantly existed in the prostate stromal cells and the ER mRNA had no difference between the hyperplasia and the normal group. Within the early phase of castration (
- Published
- 2003
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.